References:
1. Kozlov M, Levit EK, Silvers DN, Brichkov I. Severe Esophageal Lichen
Planus Treated With Tofacitinib. Cutis. 2023;111(3):155-63.
2. Di Lernia V. Targeting the IFN-γ/CXCL10 pathway in lichen planus.
Medical Hypotheses. 2016;92:60-1.
3. Uçmak D, Azizoğlu R, Harman M. Palmoplantar lichen planus: a report
of four cases. J Clin Exp Invest www clinexpinvest org Vol. 2011;2(1).
4. Kılıç FA, Baysak S, Esim AG, Lebe B. A case of erosive lichen planus
with plantar involvement. 2017.
5. Goucha S, Khaled A, Bennani Z, Rammeh S, Zéglaoui F, Zermani R, et
al. Erosive lichen planus of the soles: Effective response to
prednisone. Dermatology and therapy. 2011;1:20-4.
6. Kandula P, Elosiebo R, Mousdicas N. Plantar ulcerative lichen planus:
rapid improvement with a novel triple-therapy approach. Cutis.
2018;102(2):131-5.
7. Miotti G, Zingaretti N, Guarneri G, Manfrè V, Errichetti E, Stinco G,
et al. Autologous micrografts and methotrexate in plantar erosive lichen
planus: healing and pain control. A case report. Case Reports in Plastic
Surgery and Hand Surgery. 2020;7(1):134-8.
8. Sălăvăstru C, Tiplica GS. Therapeutic Hotline: Ulcerative lichen
planus–treatment challenges. Dermatologic Therapy. 2010;23(2):203-5.
9. Plante J, Eason C, Snyder A, Elston D. Tofacitinib in the treatment
of lichen planopilaris: A retrospective review. Journal of the American
Academy of Dermatology. 2020;83(5):1487-9.
10. Tegtmeyer K, Zhao J, Maloney NJ, Atassi G, Beestrum M, Lio PA.
Off-label studies on tofacitinib in dermatology: a review. Journal of
Dermatological Treatment. 2021;32(4):399-409.
11. Damsky W, Wang A, Olamiju B, Peterson D, Galan A, King B. Treatment
of severe lichen planus with the JAK inhibitor tofacitinib. Journal of
Allergy and Clinical Immunology. 2020;145(6):1708-10. e2.
12. Kozlov M, Levit EK, Silvers DN, Brichkov I. Severe Esophageal Lichen
Planus Treated With Tofacitinib. Cutis. 2023;111(3).